Home/Filings/4/0001193125-25-267057
4//SEC Filing

Breedlove Robert Charles 4

Accession 0001193125-25-267057

CIK 0001783183other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 4:30 PM ET

Size

5.3 KB

Accession

0001193125-25-267057

Insider Transaction Report

Form 4
Period: 2025-11-03
Breedlove Robert Charles
Principal Accounting Officer
Transactions
  • Sale

    Common Stock

    2025-11-03$13.51/sh524$7,07947,407 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    6,945.4
Footnotes (1)
  • [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

Documents

1 file

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1
  • filerCIK 0002066645

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:30 PM ET
Size
5.3 KB